CTKB logo

CYTEK BIOSCIENCES INC

CTKBNASDAQ
๐Ÿ† #2695 by market capEarnings Nov 4US Equity
$5.76โ–ฒ $0.02 (+0.35%)
๐ŸŒ™ After hours$5.76โ–ฒ 0.00%Regular close ยท extended-hours price shown
๐Ÿ””
Track CTKB
Get earnings, price moves & breaking news on Telegram
Track
24hโ–ฒ 0.3%
7dโ–ฒ 1.8%
14dโ–ฒ 16.8%
30dโ–ฒ 20.3%
ytdโ–ฒ 14.2%
1yโ–ฒ 65.5%
๐ŸฆMarket Cap
$744M
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
+0.5%
Slowing
๐Ÿ“ŠGross Margin
53.2%
Healthy
๐Ÿ’ตFCF Margin
-5.8%
Thin
โš–๏ธP/S Ratio
3.6x
Fair
Otter Score
76
Good

Trading Snapshot

Day Range
$5.67 โ€“ $5.79
52-Week Range
$3.31 โ€“ $6.18
Volume
$1.81B
Avg Volume
$2.39B
Shares Outstanding
129.1M
Next Earnings
Dec 3, 2026

Fundamentals Snapshot

Annual Revenue
$201M
Last Q Revenue
$48M
P/E Ratio
-9.2
P/S Ratio
3.6x
EPS (TTM)
$-0.62
Dividend Yield
0.00%
Dilution (1yr)
โˆ’0.8%

Why Investors Own CTKB

  • โœ“High-growth profile โ€” revenue up +29.6% YoY with expanding US Equity exposure.
  • โœ“Healthy economics โ€” 35% gross margin and 28% free-cash-flow margin.
  • โœ“New products and segments could unlock additional revenue streams.
โš ๏ธ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

CTKB logo

CYTEK BIOSCIENCES INC

CTKB
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$201Mโ–ฒ +0.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
51.8%โ–ผ โˆ’6.5% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isnโ€™t profitable yet.
โˆ’$40Mโ–ฒ +96.8% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
โˆ’$9Mโ–ผ โˆ’140.1% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing ownerโ€™s slice.
128.2Mโ–ผ โˆ’0.8% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$67Mโ–ผ โˆ’$15M YoY
StockOtter ยท stockotter.space

About CYTEK BIOSCIENCES INC

Cytek Biosciences, Inc. is a company dedicated to cell analysis solutions, offering advanced tools that facilitate scientific progress in both biomedical research and clinical settings. Their primary offerings include the Aurora and Northern Lights spectrum flow cytometers. These instruments conduct comprehensive cell analysis by leveraging fluorescence signatures from multiple lasers to differentiate between various fluorescent tags on individual cells. Complementing these, the Aurora Cell Sorter system utilizes full spectrum profiling technology to broaden the range of potential applications in cell analysis. Beyond instrumentation, Cytek provides essential reagents and kits. These include cFluor reagents, which are antibodies conjugated with fluorochromes, specifically designed to identify target cells for analysis on their systems. They also offer a 25-color immunoprofiling assay, a ready-to-use solution for pinpointing major human immune cell subpopulations like TBNK cells, monocytes, dendritic cells, and basophils. To streamline laboratory operations, the company offers automated micro-sampling and sample loader systems. These automated plate loaders are engineered to integrate seamlessly with the Aurora and Northern Lights systems. The intuitive SpectroFlo software accompanies these systems, simplifying the workflow from quality control through to data analysis. Cytek also provides comprehensive customer support resources. Cytek's diverse client base includes pharmaceutical and biopharmaceutical companies, academic research institutions, and clinical research organizations. The company distributes its products through a direct sales force and dedicated support teams in North America, Europe, China, and the Asia-Pacific region. Additionally, it partners with distributors and sales agents to serve markets across European, Latin American, Middle Eastern, and other Asia-Pacific countries. Originally established in 1992 as Cytoville, Inc., the company officially adopted the name Cytek Biosciences, Inc. in August 2015. Its corporate headquarters are situated in Fremont, California.

๐Ÿฆฆ

Otter Score Breakdown

How it's scoredFive components, each rated 1โ€“5โ˜… and equally weighted (20%), averaged to a 0โ€“100 score:๐Ÿ’Ž Quality โ€” gross margin๐Ÿš€ Growth โ€” revenue YoYโš–๏ธ Valuation โ€” P/S ratioโšก Momentum โ€” 30-day price change๐Ÿ’ง Dilution โ€” 1-yr share issuance (buybacks score higher)
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿ’งDilutionโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Good
76/100

Analyst Price Target

โ“˜
Average Target
$6.08
โ–ฒ +5.6% Upside
High Target$7.52
Low Target$5.18
Based on 12 analysts

Latest News & Updates

Defense Worldยท1d ago

1,315,332 Shares in Cytek Biosciences, Inc. $CTKB Acquired by Bank of America Corp DE

Bank of America Corp DE purchased a new position in shares of Cytek Biosciences, Inc. (NASDAQ: CTKB) during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commi

GlobeNewsWireยท6d ago

Cytekยฎ Biosciences Extends Capabilities Within Cytek Cloud Digital Ecosystem with New Cloud Analysis Tool

Cytek has expanded its Cytekยฎ Cloud digital ecosystem with a new Cloud Analysis tool to create the industry's first end-to-end flow cytometry platform.

Defense Worldยท11d ago

Critical Survey: Revvity (NYSE:RVTY) vs. Cytek Biosciences (NASDAQ:CTKB)

Revvity (NYSE: RVTY - Get Free Report) and Cytek Biosciences (NASDAQ: CTKB - Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of

Zacks Investment Researchยท12d ago

Is the Options Market Predicting a Spike in Cytek Biosciences Bank Stock?

Investors need to pay close attention to CTKB stock based on the movements in the options market lately.

Seeking Alphaยท13d ago

Cytek Biosciences, Inc. (CTKB) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Cytek Biosciences, Inc. (CTKB) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

GlobeNewsWireยท20d ago

Sysmex Europe and Cytekยฎ Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry

FREMONT, Calif., and HAMBURG, Germany, Sept.